Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

A phase 1B trial of vocimagene amiretrorepvec in patients with advanced solid tumors: Safety, tumor homing, and immune modulatory effects

Molecular Therapy(2025)10.1016/j.ymthe.2025.08.027Source: DataRank Database

A phase 1B trial of vocimagene amiretrorepvec in patients with advanced solid tumors: Safety, tumor homing, and immune modulatory effects is a research paper published in Molecular Therapy (2025). On theSindex it has a DataRank of 0. It has been cited 2 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access2 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (2 grants)Impact (FWCI 0.93)OA: greenTopics (48)IDs (PubMed, PMC, OpenAlex)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (15)

Jordi Rodon ORCID,Shree Venkat ORCID,Arthur Donahue,Amber Thomassen ORCID,William P. Accomando

Live enrichment

PubMed:40842153 PMC:PMC12628180 OpenAlex:https://openalex.org/W4413401497

National Institutes of Health

Grant: P30CA240139

National Cancer Institute

FWCI

0.93

Citation Percentile

0.8%

Citation Trend

2026

greenLicense: cc-by-nc-nd

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/12628180

publisherhttps://api.elsevier.com/content/article/PII:S1525001625006574?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S1525001625006574?httpAccept=text/plain

journalhttps://doi.org/10.1016/j.ymthe.2025.08.027

Fields of Study

Cancer Immunotherapy and BiomarkersHepatocellular Carcinoma Treatment and PrognosisRadiopharmaceutical Chemistry and ApplicationsHumansFemaleMaleNeoplasmsMiddle AgedAgedGenetic VectorsAdultTumor MicroenvironmentCytosine DeaminaseRetroviridaeTreatment OutcomeFlucytosineGenetic TherapyImmunomodulation

MeSH Terms

AdultAgedFemaleFlucytosineGenetic VectorsHumansMaleMiddle AgedNeoplasmsRetroviridaeGenetic TherapyTreatment OutcomeCytosine DeaminaseImmunomodulationTumor Microenvironment

Keywords

Homing (biology)Immune systemSolid tumorMedicineImmunologyCancer researchBiologyInternal medicineCancerRetroviral vectorImmunotherapyCancer gene therapyProdrugSolid TumorsPhase 1 Clinical Trial